|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.36 INR | -1.80% |
|
-4.60% | -46.63% |
Business description: Nectar Lifesciences Limited

Number of employees: 1,786
Sales by Activity: Nectar Lifesciences Limited
| Fiscal Period: March | 2021 (INR) | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) |
|---|---|---|---|---|---|
Pharmaceuticals Products | 15.43B | 16.69B | 15.24B | 16.85B | 16.7B |
Geographical breakdown of sales: Nectar Lifesciences Limited
| Fiscal Period: March | 2021 (INR) | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) |
|---|---|---|---|---|---|
India | 9.66B | 11.81B | 8.45B | 11.46B | 11.72B |
Outside India | 7.98B | 7.45B | 9.01B | 7.79B | 7.37B |
Executive Committee: Nectar Lifesciences Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Kapoor
DFI | Director of Finance/CFO | 68 | 2022-11-13 |
| Compliance Officer | - | 2025-03-31 |
Composition of the Board of Directors: Nectar Lifesciences Limited
| Director | Title | Age | Since |
|---|---|---|---|
Sanjiv Goyal
CHM | Chairman | 66 | 1995-06-26 |
Rupinder Tewari
BRD | Director/Board Member | 69 | 2019-02-10 |
| Director/Board Member | 75 | 2021-09-20 | |
Indu Pal Kaur
BRD | Director/Board Member | 61 | 2022-08-01 |
| Director/Board Member | 49 | 2025-05-31 |
Company details: Nectar Lifesciences Limited

Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.80% | -4.60% | -41.07% | -51.93% | 21.24M | ||
| +0.57% | +0.13% | +16.45% | +78.10% | 48.31B | ||
| -0.50% | -0.41% | +67.13% | +107.90% | 35.33B | ||
| -1.56% | -3.13% | -4.88% | +32.80% | 11.85B | ||
| -1.11% | -3.73% | +16.41% | +81.64% | 11.64B | ||
| -0.37% | -0.19% | +36.48% | +136.73% | 8.99B | ||
| -0.27% | +0.42% | +51.66% | -6.22% | 6.93B | ||
| -0.77% | -3.00% | +13.55% | +32.01% | 6.72B | ||
| +0.24% | -4.02% | +2.19% | +192.78% | 6.43B | ||
| +1.60% | -9.55% | -30.77% | +8.47% | 5.66B | ||
| Average | -0.40% | -1.85% | +12.71% | +61.23% | 14.19B | |
| Weighted average by Cap. | -0.15% | -0.93% | +27.59% | +81.84% |
- Stock Market
- Stocks
- NECLIFE Stock
- Company Nectar Lifesciences Limited
Select your edition
All financial news and data tailored to specific country editions

















